Maxona Pharmaceuticals Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
1
- Latest Deal Type
-
Series C
- (In Progress)
- Latest Deal Amount
-
$12M
- Investors
-
1
Maxona Pharmaceuticals General Information
Description
Operator of a pharmaceutical company intended to develop novel therapeutics for the treatment of moderate to severe pain without any side effects. The company leverages technology to develop non-opioid, non-NSAID, and non-CBD analgesia using nefopam, a centrally acting agent that exerts antinociceptive effects via a triple neurotransmitter mechanism of action, enabling patients to get an opioid-free route for treating pain.
Contact Information
Website
www.maxonapharm.comCorporate Office
- 101 Lindenwood Drive
- Suite 225
- Malvern, PA 19355
- United States
Corporate Office
- 101 Lindenwood Drive
- Suite 225
- Malvern, PA 19355
- United States
Maxona Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series C) | 04-Jun-2025 | $12M | In Progress | Clinical Trials - Phase 1 | ||
| 2. Later Stage VC (Series B) | 22-Apr-2024 | Completed | Pre-Clinical Trials | |||
| 1. Later Stage VC (Series A) | 05-May-2021 | $10M | $10M | Completed | Pre-Clinical Trials |
Maxona Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 10,000,000 | $0.001000 | $1 | $1 | 1x | $1 | 24.81% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Maxona Pharmaceuticals Comparisons
Industry
Financing
Details
Maxona Pharmaceuticals Competitors (5)
One of Maxona Pharmaceuticals’s 5 competitors is Heron Therapeutics, a Formerly VC-backed company based in Cary, NC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Heron Therapeutics | Formerly VC-backed | Cary, NC | ||||
| Knoa Pharma | Corporate Backed or Acquired | Stamford, CT | ||||
| Assertio Holdings | Formerly VC-backed | Lake Forest, IL | ||||
| Collegium Pharmaceutical | Formerly VC-backed | Stoughton, MA | ||||
| Teva Pharmaceutical Industries | Corporation | Tel Aviv, Israel |
Maxona Pharmaceuticals Signals
Maxona Pharmaceuticals Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bleichroeder (New York) | Hedge Fund | Minority |
Maxona Pharmaceuticals FAQs
-
When was Maxona Pharmaceuticals founded?
Maxona Pharmaceuticals was founded in 2015.
-
Where is Maxona Pharmaceuticals headquartered?
Maxona Pharmaceuticals is headquartered in Malvern, PA.
-
What is the size of Maxona Pharmaceuticals?
Maxona Pharmaceuticals has 1 total employees.
-
What industry is Maxona Pharmaceuticals in?
Maxona Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Maxona Pharmaceuticals a private or public company?
Maxona Pharmaceuticals is a Private company.
-
What is the current valuation of Maxona Pharmaceuticals?
The current valuation of Maxona Pharmaceuticals is .
-
What is Maxona Pharmaceuticals’s current revenue?
The current revenue for Maxona Pharmaceuticals is .
-
How much funding has Maxona Pharmaceuticals raised over time?
Maxona Pharmaceuticals has raised $17M.
-
Who are Maxona Pharmaceuticals’s investors?
Bleichroeder (New York) has invested in Maxona Pharmaceuticals.
-
Who are Maxona Pharmaceuticals’s competitors?
Heron Therapeutics, Knoa Pharma, Assertio Holdings, Collegium Pharmaceutical, and Teva Pharmaceutical Industries are competitors of Maxona Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process